May 20, 2015

Prevention remains a priority for consumers heading into cough-cold season, as evidenced by the sales of two brands well known for their immunity-boosting benefits.

May 12, 2015

Aidance Scientific launched a Walgreens exclusive - Terrasil Shingles Skincare ointment.

May 1, 2015

Camber Pharmaceuticals on Friday announced the launch of famciclovir tablets in 125-, 250- and 500-mg dosage strengths. 

April 2, 2015

Alere's i Strep A test received marketing clearance from the Food and Drug Administration on Thursday. 

March 30, 2015

Half of adults would say "no way" to meeting someone for a date if they had a cold sore, according to a Carmex survey. 

March 4, 2015

Immunity boosters and hand sanitizer are on most shopping lists as consumers prepare their families for the inevitable sniffles, sneezes and coughs associated with the cold and flu season.

February 26, 2015

The CDC’s Advisory Committee on Immunization Practices made a unanimous recommendation for use of meningococcal group B vaccines to vaccinate high-risk groups in the United States.

February 26, 2015

A team of researchers at Columbia Engineering has developed a low-cost smartphone accessory that can perform a point-of-care test for HIV or syphilis in just 15 minutes.

 

February 23, 2015

A centralized notification system for immunization reminders would significantly improve childhood immunization rates, according to a study pubished in  JAMA Pediatrics

February 10, 2015

PricewaterhouseCoopers released a new spotlight on the dangers of antimicrobial resistance.

 

February 10, 2015

A new study funded by the Bay Area Lyme Foundation and conducted by Stanford School of Medicine researchers has found that loratadine may be able to help treat Lyme disease.

February 5, 2015

As many as 43% of women keep a cough-cold product in their desk during the winter months “just in case” they get sick, according to a survey conducted on behalf of WorkPlace Impact.

February 4, 2015

Are community-based pharmacists underused in the care of persons living with HIV? 

January 26, 2015

The Food and Drug Administration last week announced approval for Bexsero, a vaccine intended to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B in individuals 10 years through 25 years of age.

 

January 7, 2015

Three supplement categories are really helping to drive the business today.

January 7, 2015

Researchers at the University of North Carolina at Chapel Hill and North Carolina State University have uncovered a novel approach to creating inhalable vaccines using nanoparticles that shows promise for targeting such lung-specific diseases as influenza, pneumonia and tuberculosis.

December 8, 2014

Seasonal flu vaccines may protect individuals not only against the strains of flu they contain, but also against many additional types, according to a study published this week in mBio, the online open-access journal of the American Society for Microbiology.

November 26, 2014

Just 30% of Americans with HIV had the virus under control in 2011, and approximately two-thirds of those whose virus was out of control had been diagnosed but were no longer in care.

November 13, 2014

Pharmacists can make use of a suite of resources on Ebola virus specifically designed for those who work in the community sector as of Thursday.

November 10, 2014

The Centers for Disease Control and Prevention on Friday ordered $2.7 million in personal protective equipment to increase strategic national stockpile supplies to assist U.S. hospitals caring for Ebola patients.

November 10, 2014

A national survey from Rite Aid and National Foundation for Infectious Diseases released Monday found that the majority of adult women living in the United States do not believe they are up to date on vaccinations to protect against many preventable diseases. 

November 3, 2014

A potentially breathable, respiratory vaccine in development has been shown to provide long-term protection for nonhuman primates against the Ebola virus.

 

October 31, 2014

The response to the current global Ebola scare from both the pharmaceutical and pharmacy industries has been nothing short of remarkable. Precautionary preparations have been made to address the Ebola concerns in the United States; several pharmaceutical manufacturers have been working around the clock toward an Ebola vaccine and treatment; and there has been an outpooring of goods that have been directed to help with the outbreak in West Africa. 

Ebola is not a problem in the United States, at least not yet (nor hopefully will it ever be), but the pharmaceutical community is stepping up to help around the world. And in the U.S., there is much being done to help the pharmacy world prepare.

 

October 31, 2014

As many as 62% of attendees at the Academy of Integrative Health & Medicine annual conference this week said that the most important factor in stopping Ebola in the United States is controlling the virus and caring for afflicted patients in West Africa.